Aytu Biopharma (AYTU) Cash from Operations Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) Cash from Operations Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.69% |
| Sep 30, 2025 | 40.08% |
| Jun 30, 2025 | 18.73% |
| Mar 31, 2025 | -18.26% |
| Dec 31, 2024 | 19.88% |
| Sep 30, 2024 | 16.82% |
| Jun 30, 2024 | 25.67% |
| Mar 31, 2024 | 40.16% |
| Dec 31, 2023 | 49.96% |
| Sep 30, 2023 | 40.14% |
| Jun 30, 2023 | 32.36% |
| Mar 31, 2023 | 6.51% |
| Dec 31, 2022 | 4.31% |
| Sep 30, 2022 | -16.62% |
| Jun 30, 2022 | -16.76% |
| Mar 31, 2022 | -30.67% |
| Dec 31, 2021 | -25.45% |
| Sep 30, 2021 | 6.55% |
| Jun 30, 2021 | -18.78% |
| Dec 31, 2020 | 3.37% |